Tous Actualités
Suivre
Abonner Epitomee Medical

Epitomee Medical

Epitomee Medical to Present the Epitomee Breakthrough Oral Delivery Platform at PODD 2024 Conference

Caesarea, Israel (ots/PRNewswire)

Epitomee Medical Ltd. (TASE: EPIT) announces today that the company leadership intends to present Epitomee's Oral Delivery of Biologics Platform at the 14th Annual PODD Conference - Partnership Opportunities in Drug Delivery, taking place in Boston, MA, October 28-29, 2024.

Presentation Title: "Breakthrough Device for Oral Delivery of Biologics".

Date & Time: October 22, 2024, 2:30 PM – 2:45 PM

Presenter: Dr. Gil Cohen, PhD, VP R&D

Epitomee's presentation will cover the following topics:

  • The Epitomee Platform enables oral delivery of significant amounts of large molecules, including proteins and peptides.
  • The platform dramatically boosts bioavailability, offering game-changing alternative to traditional injections.
  • Epitomee's advanced, needle-free platform precisely transports drugs to the small intestine and across the GI wall, ensuring effective bioavailability.

The PODD Conference, in its 14th year, brings together over 800+ delegates from pharma, biotech, drug delivery, investors and academia. The event fosters collaboration across industries, to develop more effective therapies, improve the patient experience and extend the lifecycle of medicines. PODD features innovative technologies to enhance the delivery of various drug types, including proteins, peptides, oncology therapeutics, small molecules and others. This year's annual keynote will be delivered by Dr. Robert Langer of MIT.

Join us at PODD 2024 to learn how Epitomee Medical is transforming biologics delivery.

About Epitomee Medical:

Epitomee Medical, co-founded by Shimon Eckhouse, PhD and led by CEO Dan Hashimshony, PhD, is a pioneering health solutions company, committed to advancing innovative therapies. With a focus on safety, efficacy, and improving quality of life, Epitomee leads advancements in weight management and biologic drug delivery. For more information, visit: epitomeemedical.com

Contact details: Safi Landskroner, VP of Business Development: safi@epitomeemedical.com

Photo - https://mma.prnewswire.com/media/2530888/PODD_2024.jpg

Logo - https://mma.prnewswire.com/media/2506356/Epitomee_Medical_Logo.jpg

View original content: https://www.prnewswire.co.uk/news-releases/epitomee-medical-to-present-the-epitomee-breakthrough-oral-delivery-platform-at-podd-2024-conference-302276353.html

Contact:

+972-54-4758914

Plus de actualités: Epitomee Medical
Plus de actualités: Epitomee Medical
  • 16.09.2024 – 17:07

    Epitomee Medical Announces FDA Clearance of its Capsule, Weight Management Device

    Caesarea, Israel (ots/PRNewswire) - Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise. Epitomee Medical Ltd. (TASE: EPIT), announced that the United States Food and Drug Administration (FDA) has officially ...

  • 06.03.2024 – 15:01

    Epitomee® announces the filing of a novel Weight Loss Capsule for FDA clearance

    Caesarea, Israel (ots/PRNewswire) - Epitomee® (TASE: EPIT) announced today that on February 27, 2024, it has submitted its Weight Loss Capsule for FDA clearance in the USA, reaching a significant milestone in the company's journey. The Epitomee® capsule offers an innovative, orally administered, drug free, and clinically proven as effective and safe solution, for ...